Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
Sebastian Schwind, Clara D. Bloomfield(North Shore University Hospital), Heiko Becker(University of Freiburg), Klaus H. Metzeler(University Hospital Leipzig), Michael D. Radmacher, Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Maria R. Baer(University of Maryland, Baltimore), Jessica Kohlschmidt(The Ohio State University), Guido Marcucci(City of Hope), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard A. Larson(Urbana University), Andrew J. Carroll(University of Alabama at Birmingham), Krzysztof Mrózek(The Ohio State University), Bayard L. Powell(Atrium Health Wake Forest Baptist), Susan P. Whitman(The Ohio State University Wexner Medical Center), Yue-Zhong Wu(University of Iowa), Kati Maharry(Peter MacCallum Cancer Centre)
Cited by 52
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k